This article summarizes the safety and efficacy of antibiotics in pregnancy, including vancomycin, a glycopeptide antibiotic. It also discusses the pharmacokinetic changes and the FDA pregnancy risk categories of antibiotics.
Category C: the manufacturer has received reports on the use of vancomycin in pregnancy without adverse fetal effects. BREASTFEEDING
Pregnancy. Teratogenic Effects: Pregnancy Category C. In a controlled clinical study, vancomycin was administered to pregnant women for serious staphylococcal
This is a pregnancy category C drug when one uses it as an injection. Overall, vancomycin is a good choice for empiric therapy in the moderate to severely
yielding results suggestive of a nonsusceptible category, organism identification and vancomycin susceptibility test results Pregnancy Category C. Animal
Vancomycin Hydrochloride (van koe mye' sin) Vancocin PREGNANCY CATEGORY C PREGNANCY CATEGORY B (PULVULES) Drug Class Antibiotic Therapeutic
Linezolid is a pregnancy category C drug, and caution is urged if used in breastfeeding mothers. The safety and efficacy, Vancomycin-resistant Enterococcus faecium
Pregnancy: Teratogenic Effects, Category C Animal reproduction studies have not been conducted with vancomycin hydrochloride. It is not known whether vancomycin hydrochloride can affect reproduction capacity. In a controlled clinical study, the potential ototoxic and nephrotoxic effects of vancomycin hydrochloride on infants
In contrast, intravenous vancomycin injection is category C. Vancomycin should not be used during pregnancy unless the benefits outweigh the risks of the medication. If treatment with vancomycin is necessary, close monitoring of maternal blood is recommended to reduce the risk of ototoxicity and nephrotoxicity in the fetus.
Comments